Using CT Angiography to Categorize & Stratify Risk in Patients with Subclinical to Unstable Coronary Artery Disease

 

 

 

  • Vulnerable Plaque & Ischemic Plaque Phenotypes 
  • Current usage & limitations of CTA for CAD    
  • Non-invasive plaque characterization from CTA    
  • ElucidVivo Plaque Analysis Software & Case Reviews 
  • Utilizing ElucidVivo in clinical practice    
  • Q&A

 

 

Gregg Stone


Gregg W. Stone, MD
Mount Sinai Heart Health 
System, New York, NY



 
Blankstein Ron Blankstein, MD
Brigham and Women’s Hospital, Boston, MA
Renu Vimani, MD Renu Virmani, MD
CVPath Institute, 
Gaithersburg, MD
U. Joseph Schoepf, MD


U. Joseph Schoepf, MD
The Medical University of South Carolina, Charleston, SC



 
Tony Das, MD Tony Das, MD
Baylor Heart Hospital, Plano, TX
   

 

 

 

 


 

This program is supported by: Using CT Angiography to Categorize & Stratify Risk in Patients with Subclinical to Unstable Coronary Artery Disease